Active ingredients: Atovaquone
Wellvone 750 mg/5 ml oral suspension.
Wellvone oral suspension is a bright yellow liquid.
Each ml of suspension contains 150 mg atovaquone.
A unit dose of 5 ml contains 750 mg atovaquone.
For the full list of excipients, see section 6.1.
Atovaquone is a selective and potent inhibitor of the eukaryotic mitochondrial electron transport chain in a number of parasitic protozoa and the parasitic fungus P. jiroveci. The site of action appears to be the cytochrome bc1 complex (complex III).
Tutti Frutti Flavour (Firmenich 51.880/A) containing sweet orange oil, concentrated orange oil, propylene glycol, benzyl alcohol, vanillin, acetic aldehyde, amyl acetate and ethyl butyrate.
A 240 ml high density polyethylene bottle with child resistant polypropylene closure, containing 226 ml of atovaquone suspension.
A 5 ml measuring spoon (polypropylene) is included.
Glaxo Wellcome UK Ltd, trading as GlaxoSmithKline UK, 980 Great West Road, Brentford, Middlesex, TW8 9GS
Date of first authorisation: 25 March 1997
Date of latest renewal: 21 May 2006